We have compiled a list of manufacturers, distributors, product information, reference prices, and rankings for medicine.
ipros is IPROS GMS ・ IPROS One of the largest technical database sites in Japan that collects information on.

medicine Product List and Ranking from 36 Manufacturers, Suppliers and Companies | IPROS GMS

Last Updated： Aggregation Period:Feb 18, 2026～Mar 17, 2026
This ranking is based on the number of page views on our site.

medicine Manufacturer, Suppliers and Company Rankings

Last Updated： Aggregation Period:Feb 18, 2026～Mar 17, 2026
This ranking is based on the number of page views on our site.

  1. マーケットリサーチセンター Tokyo//Service Industry
  2. null/null
  3. Panorama Data Insights Ltd. Tokyo//Testing, Analysis and Measurement
  4. 4 大塚化学 Tokyo//Chemical
  5. 5 立山化成 Toyama//Manufacturing and processing contract
Go to Company Ranking

medicine Product ranking

Last Updated： Aggregation Period:Feb 18, 2026～Mar 17, 2026
This ranking is based on the number of page views on our site.

  1. Contract development and manufacturing (CDMO) business for mid-sized molecules (oligonucleotides and peptides) active pharmaceutical ingredients.
  2. Pharmaceutical CDMO services 大塚化学
  3. Tateyama Kasei Co., Ltd. Kyushu Factory 立山化成
  4. 4 Development of various types of medium-sized molecule (nucleic acid, peptide) pharmaceuticals (processes, analytical methods, etc.)
  5. 4 [Research Material] The Global Market for Acetylsalicylic Acid マーケットリサーチセンター

medicine Product List

301～330 item / All 612 items

Displayed results
[Research Material] The Global Market for Chagas Disease Treatments

[Research Material] The Global Market for Chagas Disease Treatments

World Market for Chagas Disease Treatments: Cz-007, Cz-008, D-121, DNDI-0690, EPLBS-1246, EPLB ...

This research report (Global Chagas Disease Drug Market) investigates and analyzes the current status and outlook for the global market for Chagas disease treatment drugs over the next five years. It includes information on the overview of the global Chagas disease treatment drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include Cz-007, Cz-008, D-121, DNDI-0690, EPLBS-1246, EPLBS-967, and others, while the segments by application focus on hospitals, clinics, and others. The regional segments calculate the market size for Chagas disease treatment drugs by dividing them into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in the Chagas disease treatment drug sector, product and business overviews, and sales performance.

  • Other services
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Human Immunodeficiency Virus (HIV)-1 Therapeutics

[Research Material] Global Market for Human Immunodeficiency Virus (HIV)-1 Therapeutics

Global Market for Human Immunodeficiency Virus (HIV)-1 Treatment Drugs: Nucleoside Analog Reverse Transcriptase Inhibitors (NRTI), Non-Nucleoside Reverse ...

This research report (Global Human Immunodeficiency Virus (HIV)-1 Therap) investigates and analyzes the current state and outlook for the global market of human immunodeficiency virus (HIV)-1 therapeutics over the next five years. It includes information on the global overview of the HIV-1 therapeutics market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type for HIV-1 therapeutics include nucleoside analog reverse transcriptase inhibitors (NRTI), non-nucleoside reverse transcriptase inhibitors (NNRTI), entry/fusion inhibitors, protease inhibitors (PI), integrase inhibitors, and co-receptor antagonists. The segments by application focus on hospitals, clinics, and laboratories. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for HIV-1 therapeutics.

  • Other services
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Treatment of Chronic Idiopathic Constipation (CIC)

[Research Material] Global Market for Treatment of Chronic Idiopathic Constipation (CIC)

World Market for Chronic Idiopathic Constipation (CIC) Treatments: Lubiprostone, Linaclotide, Others, Hospitals & Clinics, Outpatient Surgical Centers, Long-term Care...

This research report (Global Chronic Idiopathic Constipation (CIC) Drugs Market) investigates and analyzes the current status and future outlook of the global market for chronic idiopathic constipation (CIC) treatment drugs over the next five years. It includes information on the overview of the global chronic idiopathic constipation (CIC) treatment drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments for chronic idiopathic constipation (CIC) treatment drugs by type include lubiprostone, linaclotide, and others, while the segments by application focus on hospitals/clinics, outpatient surgical centers, nursing centers, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for chronic idiopathic constipation (CIC) treatment drugs. It also includes the market share of major companies in the chronic idiopathic constipation (CIC) treatment drug market, product and business overviews, and sales performance.

  • Other services
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Chronic Lymphocytic Leukemia (CLL) Treatment Drugs

[Research Material] Global Market for Chronic Lymphocytic Leukemia (CLL) Treatment Drugs

World Market for Chronic Lymphocytic Leukemia (CLL) Treatments: Injectable, Oral, Hospitals, Clinics

This research report (Global Chronic Lymphocytic Leukemia Therapeutics M) investigates and analyzes the current status and outlook for the global market of chronic lymphocytic leukemia (CLL) therapeutics over the next five years. It includes information on the overview of the global CLL therapeutics market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type for CLL therapeutics focus on injectable and oral forms, while the segments by application target hospitals and clinics. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for CLL therapeutics. It also includes the market share of major companies in the CLL therapeutics sector, product and business overviews, and sales performance.

  • Other services
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Atrophic Gastritis Treatment

[Research Material] The Global Market for Atrophic Gastritis Treatment

Global Market for Atrophic Gastritis Treatment: Coatings, Antibiotics, Vitamin B-12, Hospital Pharmacies, Retail Pharmacies, Drugstores, Online Pharmacies

This research report (Global Atrophic Gastritis Treatment Market) investigates and analyzes the current state and outlook for the global market for atrophic gastritis treatment over the next five years. It includes information on the overview of the global atrophic gastritis treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the atrophic gastritis treatment market focus on coating agents, antibiotics, and vitamin B-12, while the segments by application target hospital pharmacies, retail pharmacies, drugstores, and online pharmacies. The regional segments calculate the market size for atrophic gastritis treatment by dividing it into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in atrophic gastritis treatment, product and business overviews, and sales performance.

  • Other services
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Castleman Disease Treatment

[Research Material] The Global Market for Castleman Disease Treatment

Global Market for Castleman Disease Treatment: Monoclonal Antibodies, Chemotherapy, Radiation Therapy, Immunotherapy, Corticosteroids, Antiviral Drugs, Disease ...

This research report (Global Castleman Disease Treatment Market) investigates and analyzes the current state and outlook for the global market for Castleman disease treatment over the next five years. It includes information on the overview of the global Castleman disease treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the Castleman disease treatment market include monoclonal antibodies, chemotherapy, radiation therapy, immunotherapy, corticosteroids, and antiviral drugs, while the segments by application focus on hospitals, clinics, and outpatient units. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for Castleman disease treatment. It also includes the market share of major companies in Castleman disease treatment, product and business overviews, and sales performance.

  • Other services
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Antifungal Drugs for Dermatophyte Nail Infections (DOT)

[Research Material] Global Market for Antifungal Drugs for Dermatophyte Nail Infections (DOT)

World Market for Antifungal Drugs for Dermatophyte Nail Infections: Topical, Oral Therapy, Hospitals, Dermatology and Podiatry Clinics, Independent Pharmacies, Mail-Order Pharmacies, Drugstores

This research report (Global Dermatophytic Onychomycosis Therapeutics (D)) investigates and analyzes the current status and outlook for the global market of dermatophytic onychomycosis therapeutics (DOT) over the next five years. It includes information on the overview of the global dermatophytic onychomycosis therapeutics (DOT) market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments for dermatophytic onychomycosis therapeutics (DOT) by type focus on topical and oral therapies, while the segments by application target hospitals, dermatology and podiatry clinics, independent pharmacies, mail-order pharmacies, and drugstores. The regional segments calculate the market size of dermatophytic onychomycosis therapeutics (DOT) by dividing it into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in dermatophytic onychomycosis therapeutics (DOT), product and business overviews, and sales performance.

  • Other services
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Treatment of Anorexia Nervosa

[Research Material] The Global Market for Treatment of Anorexia Nervosa

World Market for the Treatment of Anorexia Nervosa: Psychotherapy, Pharmacotherapy, Others, Hospitals, Clinics, Home Healthcare, Others

This research report (Global Anorexia Nervosa Treatment Market) investigates and analyzes the current state and outlook for the global market for anorexia nervosa treatment over the next five years. It includes information on the overview of the global anorexia nervosa treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the anorexia nervosa treatment market include psychotherapy, pharmacotherapy, and others, while the segments by application cover hospitals, clinics, home healthcare, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for anorexia nervosa treatment. It also includes the market share of major companies in anorexia nervosa treatment, product and business overviews, and sales performance.

  • Other services
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Oral Antidiabetic Drugs (OAD) Treatment

[Research Material] The Global Market for Oral Antidiabetic Drugs (OAD) Treatment

Global Market for Oral Antidiabetic Drugs (OAD) Treatment: Sulfonylureas, Biguanides, Intestinal α-Glucosidase Inhibitors, Others, Hospitals, Clinics...

This research report (Global Oral Antidiabetic (OAD) Treatment Market) investigates and analyzes the current state and outlook for the global market of oral antidiabetic drugs (OAD) over the next five years. It includes information on the overview of the global oral antidiabetic drug (OAD) treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments of the oral antidiabetic drug (OAD) treatment market by type include sulfonylureas, biguanides, intestinal alpha-glucosidase inhibitors, and others, while the segments by application target hospitals, clinics, diabetes treatment centers, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for oral antidiabetic drugs (OAD) treatment. It also includes the market share of major companies in the oral antidiabetic drug (OAD) treatment sector, product and business overviews, and sales performance.

  • Other services
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Angina Treatment

[Research Material] The Global Market for Angina Treatment

Global Market for Angina Pectoris Treatment: Antiplatelet Drugs, Beta-Adrenergic Blockers, Calcium Channel Blockers, Short-Acting and Long-Acting Nitroglycerin...

This research report (Global Angina Pectoris Treatment Market) investigates and analyzes the current state and outlook for the global angina pectoris treatment market over the next five years. It includes information on the overview of the global angina pectoris treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the angina pectoris treatment market include antiplatelet drugs, beta-adrenergic blockers, calcium channel blockers, short-acting and long-acting nitroglycerin, angiotensin-converting enzyme (ACE) inhibitors, and anti-ischemic drugs. The segments by application focus on hospitals, clinics, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for angina pectoris treatment. It also includes the market share of major companies in angina pectoris treatment, product and business overviews, and sales performance.

  • Other services
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Retinal Therapeutics

[Research Material] Global Market for Retinal Therapeutics

World Market for Retinal Therapeutics: Wet AMD, Diabetic Retinopathy, DME, RVO, Mcnv, Hospitals, Clinics, Others

This research report (Global Retinal Drugs Market) investigates and analyzes the current state and outlook for the global market for retinal therapeutic drugs over the next five years. It includes information on the overview of the global retinal therapeutic drugs market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include wet AMD, diabetic retinopathy, DME, RVO, and Mcnv, while the segments by application focus on hospitals, clinics, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for retinal therapeutic drugs. It also includes the market share of major companies in retinal therapeutic drugs, product and business overviews, and sales performance.

  • Other services
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Alcoholic Liver Disease Treatment

[Research Material] The Global Market for Alcoholic Liver Disease Treatment

Global Market for Alcoholic Liver Disease Treatment: Alcoholic Fatty Liver Disease, Alcoholic Hepatitis, Others, Hospital Pharmacies, Retail Pharmacies, Drugstores ...

This research report (Global Alcoholic Liver Diseases Treatment Market) investigates and analyzes the current status and outlook for the global market for alcoholic liver disease treatment over the next five years. It includes information on the overview of the global alcoholic liver disease treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the alcoholic liver disease treatment market include alcoholic fatty liver disease, alcoholic hepatitis, and others, while the segments by application include hospital pharmacies, retail pharmacies, drugstores, online pharmacies, and others. The regional segments are classified into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for alcoholic liver disease treatment. It also includes the market share of major companies in the alcoholic liver disease treatment sector, product and business overviews, and sales performance.

  • Other services
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Gaucher Disease (GD) Treatments

[Research Material] Global Market for Gaucher Disease (GD) Treatments

Global Market for Gaucher Disease (GD) Treatments: Enzyme Replacement Therapy, Substrate Reduction Therapy, Non-Neuropathic Gaucher Disease, Neuropathic Gaucher Disease

This research report (Global Gaucher Disease (GD) Drugs Market) investigates and analyzes the current status and future outlook of the global market for Gaucher disease (GD) treatment drugs over the next five years. It includes information on the overview of the global Gaucher disease (GD) treatment drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments for Gaucher disease (GD) treatment drugs by type include enzyme replacement therapy and substrate reduction therapy, while the segments by application focus on non-neuropathic Gaucher disease and neuropathic Gaucher disease. The regional segments calculate the market size for Gaucher disease (GD) treatment drugs by dividing them into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in the Gaucher disease (GD) treatment drug sector, product and business overviews, and sales performance.

  • Other services
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Ulnar Nerve Treatment

[Research Material] Global Market for Ulnar Nerve Treatment

Global Market for Ulnar Nerve Treatment: OTC Pain Relievers, Anticonvulsants, Physical Therapy, Surgery, Hospitals, Clinics, Research Centers, Others

This research report (Global Ulnar Nerve Treatment Market) investigates and analyzes the current status and outlook for the global ulnar nerve treatment market over the next five years. It includes information on the overview of the global ulnar nerve treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the ulnar nerve treatment market include OTC pain relievers, anticonvulsants, physical therapy, and surgery, while the segments by application focus on hospitals, clinics, research centers, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for ulnar nerve treatment. It also includes the market share of major companies in ulnar nerve treatment, product and business overviews, and sales performance.

  • Other services
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Global Market for Non-Alcoholic Steatohepatitis (NASH) Treatment

Global Market for Non-Alcoholic Steatohepatitis (NASH) Treatment

Global Market for Non-Alcoholic Steatohepatitis (NASH) Treatment: Off-Label, Therapeutics, Hospital Pharmacies, Online Providers, Retail Pharmacies

This research report (Global Non-Alcoholic Steatohepatitis (NASH) Treatment) investigates and analyzes the current status and outlook for the global market for non-alcoholic steatohepatitis (NASH) treatment over the next five years. It includes information on the overview of the global non-alcoholic steatohepatitis (NASH) treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments for non-alcoholic steatohepatitis (NASH) treatment by type focus on off-label and therapeutic drugs, while the segments by application target hospital pharmacies, online providers, and retail pharmacies. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for non-alcoholic steatohepatitis (NASH) treatment. It also includes the market share of major companies in non-alcoholic steatohepatitis (NASH) treatment, product and business overviews, and sales performance.

  • Other services
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Dental Infection Treatment

[Research Material] The Global Market for Dental Infection Treatment

Global Market for Dental Infection Treatment: Periodontal Abscess, Periodontal Abscess, Others, Dental Clinics, Hospitals, Others

This research report (Global Dental Infection Treatment Market) investigates and analyzes the current state and outlook for the global dental infection treatment market over the next five years. It includes information on the overview of the global dental infection treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the dental infection treatment market include periodontal abscess, dental abscess, and others, while the segments by application include dental clinics, hospitals, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for dental infection treatment. It also includes the market share of major companies in dental infection treatment, product and business overviews, and sales performance.

  • Other services
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Alzheimer's Disease Treatments

[Research Material] The Global Market for Alzheimer's Disease Treatments

World Market for Alzheimer's Disease Treatments: Donepezil, Memantine, Rivastigmine, Early to Moderate Stage, Moderate to Severe Stage

This research report (Global Alzheimer’s Therapeutics Market) investigates and analyzes the current state and outlook for the global market for Alzheimer’s disease treatments over the next five years. It includes information on the overview of the global Alzheimer’s disease treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include Donepezil, Memantine, and Rivastigmine, while the segments by application focus on early to moderate stages and moderate to severe stages. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for Alzheimer’s disease treatments. It also includes the market share of major companies in Alzheimer’s disease treatments, product and business overviews, and sales performance.

  • Other services
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Global Market for Stroke Prevention in Atrial Fibrillation (SPAF) Treatment

Global Market for Stroke Prevention in Atrial Fibrillation (SPAF) Treatment

Global Market for Stroke Prevention in Atrial Fibrillation (SPAF) Treatment: Oral Direct Thrombin Inhibitors, Oral Direct Factor Xa Inhibitors, Hospitals, Clinics ...

This research report (Global Stroke Prevention in Atrial Fibrillation (SPAF)) investigates and analyzes the current state and future outlook of the global market for stroke prevention in the treatment of atrial fibrillation (SPAF) over the next five years. It includes information on the overview of the global stroke prevention market in atrial fibrillation (SPAF) treatment, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments for stroke prevention in atrial fibrillation (SPAF) treatment by type focus on oral direct thrombin inhibitors and oral direct factor Xa inhibitors, while the segments by application target hospitals, clinics, and outpatient surgical centers. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for stroke prevention in atrial fibrillation (SPAF) treatment. It also includes the market share of major companies in stroke prevention for atrial fibrillation (SPAF) treatment, product and business overviews, and sales performance.

  • Other services
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Market Report] Global Market for Point-of-Care Diagnostic Tests

[Market Report] Global Market for Point-of-Care Diagnostic Tests

With the rapid increase in demand for swift and accurate testing, the global market for POC (point-of-care) diagnostic tests is experiencing rapid growth.

The global POC market is experiencing unprecedented growth due to the increasing demand for rapid and accurate testing solutions. Point-of-care diagnostic tests, also known as bedside testing or near-patient testing, enable timely decision-making by healthcare professionals and improve patient outcomes through rapid diagnosis and treatment. As the value of rapid and accurate testing is recognized by healthcare institutions worldwide in enhancing patient care and streamlining healthcare delivery, the global POC market is poised for continued growth. Please check the application method from the [PDF download] button or apply directly through the related links.

  • others
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Market Report] Global Organ Transplant Rejection Treatment Drug Market

[Market Report] Global Organ Transplant Rejection Treatment Drug Market

The global market for organ transplant rejection treatment drugs is rapidly expanding and is expected to reach 7 billion USD by 2031.

The global organ transplant rejection treatment drug market recorded a market size of 4.9 billion USD in 2022 and is expected to see significant expansion. It is projected to grow at a compound annual growth rate (CAGR) of 3.9% during the forecast period from 2023 to 2031, reaching an estimated value of 7 billion USD by 2031. The driving forces behind this growth are the increase in organ transplant surgeries and advancements in immunosuppressive therapies. The growth of the global organ transplant rejection treatment drug market plays a crucial role in enhancing the quality of life for transplant recipients. Continuous technological innovations and advancements will make this market extremely important in ensuring the success of organ transplant surgeries worldwide. For application methods, please check the [PDF download] button or apply directly through the related links.

  • others
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Market Report] Global Market for Neuropathic Pain Medications

[Market Report] Global Market for Neuropathic Pain Medications

The global market for neuropathic pain treatment drugs is expected to rapidly expand to $10.4 billion by 2031, alleviating suffering worldwide.

The global market for neuropathic pain medications is specialized in improving the lives of people suffering from neuropathic pain and has made significant progress. In 2022, this important market generated approximately $5.8 billion in revenue. It is projected to reach an estimated $10.4 billion by 2031, showing a stable compound annual growth rate (CAGR) of 5% during the forecast period from 2023 to 2031. Neuropathic pain is characterized by sharp, stabbing pain and burning sensations, often caused by nerve damage or dysfunction. Neuropathic pain is a complex condition that significantly impacts the quality of life for millions of people worldwide. You can check the application method by clicking the [PDF Download] button or apply directly through the related links.

  • others
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Market Report] Global Market for Psoriasis Treatments

[Market Report] Global Market for Psoriasis Treatments

The global market for psoriasis treatments is expected to rapidly expand, reaching 55.72 billion USD by 2031.

The global market for psoriasis treatments has experienced significant growth and plays a crucial role in addressing this challenging skin condition. In 2022, the market size reached 25.2 billion USD and is projected to reach 55.72 billion USD by 2031. This notable increase indicates a steady compound annual growth rate (CAGR) of 9.3% during the forecast period from 2023 to 2031. Psoriasis is a chronic skin disease affecting millions of people worldwide, characterized by red, itchy, scaly patches on the skin's surface. The increasing prevalence of psoriasis, heightened awareness, and advancements in treatment options are driving the expansion of the psoriasis treatment market. For application methods, please check the [PDF download] button or apply directly through the related links.

  • others
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Market Report] Global Market for Pulmonary Arterial Hypertension

[Market Report] Global Market for Pulmonary Arterial Hypertension

The global market for pulmonary arterial hypertension is projected to reach 10.8 billion dollars by 2031.

The global pulmonary arterial hypertension (PAH) market reached a revenue of $7 billion in 2022 and is aiming for significant growth. Projections indicate that the market will reach $10.8 billion by 2031, with a compound annual growth rate (CAGR) of 5% from 2023 to 2031. This growth reflects the increasing demand for effective treatments for this serious and life-threatening disease. Pulmonary arterial hypertension is a rare but severe condition characterized by high blood pressure in the lungs. It involves narrowing or blockage of the pulmonary arteries and capillaries, leading to increased strain on the heart and gradually worsening symptoms. Without timely and effective treatment, PAH can be life-threatening, highlighting the urgent need for advanced treatment options. For application methods, please check the [PDF download] button or apply directly through the related links.

  • others
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Market Report] Global Diabetic Nephropathy Market

[Market Report] Global Diabetic Nephropathy Market

The global diabetic nephropathy market is advancing in the fight against kidney disease, expected to reach 3.37 billion USD by 2031.

The global diabetic nephropathy market is at the forefront of combating kidney disorders in diabetic patients, offering hope and advanced treatment options. According to recent market reports, the global diabetic nephropathy market generated approximately $2 billion in revenue in 2022 and is estimated to surge to about $3.37 billion by 2031. This noteworthy growth trajectory is driven by a solid annual compound growth rate (CAGR) of 6% projected from 2023 to 2031. Diabetic nephropathy, a long-term kidney disorder, is a significant concern for those living with diabetes. This condition occurs when persistently elevated blood sugar levels cause damage to kidney function. Diabetic nephropathy can affect patients with type 2 diabetes and is primarily characterized by damage to the smallest blood vessels in the kidneys. When these small blood vessels are damaged, proteins begin to leak into the urine from both kidneys, indicating renal dysfunction. You can check the application method by clicking the [PDF Download] button or apply directly through the related links.

  • others
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Market Report] Global Nucleic Acid Medicine Market

[Market Report] Global Nucleic Acid Medicine Market

Global Nucleic Acid Drug Market: Expected to Reach 12 Billion USD by 2031 Due to Advances in Precision Medicine and Targeted Therapies.

The global nucleic acid therapeutics market is at the forefront of the pharmaceutical industry's push towards precision medicine and targeted therapies. According to recent market reports, the global nucleic acid therapeutics market is estimated to achieve approximately $4.5 billion in revenue by 2022 and surge to $12 billion by 2031. This remarkable growth trajectory is driven by powerful compounds. The compound annual growth rate (CAGR) is projected to be 11.6% from 2023 to 2031. Nucleic acid therapeutics encompass a wide range of innovative treatments, including ribonucleic acid (RNA) therapeutics and deoxyribonucleic acid (DNA) therapeutics. These therapies further include enzymes, antisense oligonucleotides, DNA aptamers, ribozymes, micro RNA, RNA decoys, and short interfering RNA, all designed to target disease-causing genes while preserving healthy cells and tissues. For application methods, please check the [PDF download] button or apply directly through the related links.

  • others
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Market Report] Global Lyme Disease Treatment Market

[Market Report] Global Lyme Disease Treatment Market

The global Lyme disease treatment market is expected to achieve steady growth, reaching 1.652 billion USD by 2031.

The global Lyme disease treatment market is aiming for significant expansion, with revenues reaching approximately $799.4 million in 2022. Recent market analysis indicates that this sector is expected to experience a robust compound annual growth rate (CAGR) of 8.4% in 2022. The forecast period is from 2023 to 2031, with an estimated value of $1.652 billion by 2031. This increase is attributed to the rising global prevalence of Lyme disease and the development of innovative treatments. As the prevalence of Lyme disease continues to rise and research efforts focus on developing more effective treatment options, the global Lyme disease treatment market is poised for continuous growth. Increased investment in research and development, expanded access to healthcare, and heightened awareness of Lyme disease among healthcare professionals and the general public are expected to lead to significant advancements in the diagnosis and treatment of this debilitating disease. For application methods, please check the [PDF download] button or apply directly through the related links.

  • others
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Current Status of Pain Treatment: Medical Needs, Basic Research, and Exploration of New Therapeutics

Current Status of Pain Treatment: Medical Needs, Basic Research, and Exploration of New Therapeutics

★What are the actual drug selection and treatment processes for chronic pain management? ★Profile of the desired medication, expected cascade, and promising future analgesic cascades.

【Lecturers】 Professor Shinsuke Hamaguchi, Department of Anesthesiology, Dokkyo Medical University Dr. Kenji Miki, Deputy Chief of Orthopedics, Amagasaki Central Hospital, Specialist in Pain Management, Osaka University Medical Hospital 【Venue】Industrial Promotion Hall, Conference Room 1【Kanagawa, Kawasaki Station】 【Date and Time】December 13, 2010 (Monday) 11:00-15:00 【Capacity】30 people *Registration will close once full. Please apply early. 【Participation Fee】45,150 yen per person (including tax, textbook fee, and tea cost) New members applying for the first time by December 3 will receive an early bird discount price of 39,900 yen. ◆For two applicants from the same organization, the fee is 69,300 yen. For more details or to consider applying, please use the URL below ▼ http://ec.techzone.jp/products/detail.php?product_id=1270

  • Company：AndTech
  • Price：10,000 yen-100,000 yen
  • Technical Seminar
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Key Points of Global Quality Assurance System and Safety Assurance in GMP for Investigational Drugs

Key Points of Global Quality Assurance System and Safety Assurance in GMP for Investigational Drugs

★A thorough explanation from the basics to global compliance measures for clinical trial drug GMP, taking into account audit experience! ★Introducing many actual concrete examples, including responses to QP!

【Instructor】QA Advisor, Doctor of Medicine, Akira Nomura 【Venue】Kawasaki City Educational and Cultural Center, Room 1 　【Kanagawa, Kawasaki】10 minutes on foot from JR and Keikyu "Kawasaki Station," 12 minutes from JR Shinagawa Station to Kawasaki Station 【Date and Time】January 26, 2011 (Wednesday) 13:00-16:30 【Capacity】30 people 【Attendance Fee】45,150 yen per person (including tax and text costs)

  • Company：AndTech
  • Price：10,000 yen-100,000 yen
  • Technical Seminar
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Tateyama Chemical Co., Ltd. Quality Assurance System

Tateyama Chemical Co., Ltd. Quality Assurance System

With "creative practice" as a keyword, we are constantly reevaluating our quality assurance system.

Our company started with the production of methyl ephedrine, an active pharmaceutical ingredient (API) for expectorants. The manufacturing of APIs and their quality control are the very roots of Tateyama Chemical. Aiming for world-class quality assurance, we achieve global-level quality assurance that complies not only with Japan's GMP, which is the standard for pharmaceutical manufacturing and quality control, but also with PIC/S GMP, to supply safe, effective, and high-quality pharmaceuticals to countries around the world. To respond to the trust of various customers and ultimately the end users, we will continuously update our quality control system. 【Management Policy】 ■ Development of new products ■ Refinement of technology ■ Thorough implementation of 5S and quality control ■ Raising awareness of environmental conservation and health and safety *For more details, please refer to the PDF materials or feel free to contact us.

  • Contract manufacturing
  • Chemicals
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Aptamer drug discovery technology

Aptamer drug discovery technology

Created using the SELEX method (in vitro artificial evolution method)! It is possible to develop various new drugs.

We would like to introduce our "Aptamer Drug Discovery Technology." Our core drug discovery technology, the "RiboART System," is built on comprehensive technologies, knowledge, and experience related to aptamer drug discovery, creating a platform (drug discovery foundation) that can be widely applied to the generation of new drug candidates. By using this system, it is possible to create various new drugs that are not limited to specific diseases or target proteins. 【Flow】 ■ SELEX method ■ Binding property measurement ■ Shortening, re-SELEX, chemical modification ■ Cell testing ■ Animal testing ■ Toxicity testing *For more details, please refer to the PDF document or feel free to contact us.

  • Other Protein Research
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

Search Keywords Related to medicine

COPYRIGHT © 2001-2026 IPROS CORPORATION ALL RIGHTS RESERVED.